Anger, Holly A <br/><br/>
Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.  [electronic resource] 

 -  The Journal of antimicrobial chemotherapy  Apr 2010 
 - 775-83 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2091 
<br/><br/><label>Standard No.: </label>10.1093/jac/dkq017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetamides--adverse effects<br/>Adult<br/>Aged<br/>Antitubercular Agents--adverse effects<br/>Bone Marrow Diseases--chemically induced<br/>Child<br/>Female<br/>Gastrointestinal Diseases--chemically induced<br/>Humans<br/>Incidence<br/>Linezolid<br/>Male<br/>Middle Aged<br/>Nervous System Diseases--chemically induced<br/>New York City<br/>Oxazolidinones--adverse effects<br/>Retrospective Studies<br/>Treatment Outcome<br/>Tuberculosis, Multidrug-Resistant--drug therapy<br/>Young Adult